Sun Pharma Advanced Research Co (NSE:SPARC) Tariff Resilience Score: 0/10 (As of Jul. 07, 2026)


NSE:SPARC Sun Pharma Advanced Research Co Ltd NSE:SPARC
67 GF Score
Price ₹261.71
GF Value ₹4,511.92
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Sun Pharma Advanced Research Co Tariff Resilience Score?

Sun Pharma Advanced Research Co has the Tariff Resilience Score of 0, which implies that the company might have .

Sun Pharma Advanced Research Co has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Sun Pharma Advanced Research Co might have .


Sun Pharma Advanced Research Co  (NSE:SPARC) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Sun Pharma Advanced Research Co Tariff Resilience Score Related Terms

NSE:SPARC
67GF Score
Sun Pharma Advanced Research Co Ltd NSE:SPARC
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sun Pharma Advanced Research Co (NSE:SPARC) Overvalued in 2026?

Based on GuruFocus' analysis, Sun Pharma Advanced Research Co stock appears to be undervalued. The current stock price of ₹261.71 is trading 94.2% below its estimated GF Value™ of ₹4,511.92. GuruFocus considers Sun Pharma Advanced Research Co to be Possible Value Trap.

Key valuation signals for NSE:SPARC:

  • Tariff Resilience Score: 0
  • GF Value™: ₹4,511.92 vs. price of ₹261.71 (94.2% below fair value)
  • GF Score™: 67/100 with 7 warning signs

No single metric tells the full story. See the NSE:SPARC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sun Pharma Advanced Research Co Business Description

Other Exchanges 532872:India
Address Off Mahakali Caves Road, 17-B, Mahal Industrial Estate, Andheri (East), Mumbai, MH, IND, 400093
Sun Pharma Advanced Research Co Ltd is an Indian specialty and generic drug manufacturing company. The company has identified pharmaceuticals research and development as its only reportable segment. The company is focused on drug discovery in focused therapy areas such as cancer and anti-inflammatory treatments. The company considers merger and acquisition investment as a potential component of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities. It derives maximum revenue from India and also has its presence in other countries.
67GF Score

Get the complete analysis for NSE:SPARC

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹261.71
Price
₹4,511.92
GF Value